Chris Throgmorton

Chris Throgmorton has built a career centered on taking responsibility and delivering results. From leading over 150 Marines to overseeing clinical trial transparency at Neurocrine Biosciences, he has consistently focused on delivering results.

In his current role as Head of Clinical Transparency at Neurocrine, Chris oversees the global strategy for clinical trial disclosure. He ensures compliance with the FDAAA 801, EU CTR, and other relevant regulations. His background in the military, biopharmaceutical, and government-regulated sectors has shaped his practical approach to leadership, enabling him to guide teams through complex requirements.

At Neurocrine, Chris established the clinical trial disclosure program, developing standard procedures, vendor oversight processes, and document management systems, including Smartsheet and SharePoint. He oversees adherence to FDA and European regulations and advises senior leaders on transparency practices.